Glenmark Generics Ltd. - (Amalgamated)
Issue Open Date NA  
Issue Closing Date NA  
Application Money  
Allotment Money  
Price Band () -  
Minimum Bid Quantity.  
Issue Size (Shares)  
Market Lot 1  
Objective

The Net Proceeds of the Issue are proposed to be utilised by the Company for the following objects:(a) Funding equity investment in the Company’s wholly owned subsidiary, Glenmark GenericsFinance S.A., Switzerland (“GGFSA”) for part payment of the loan arising out of Share PurchaseAgreement dated June 2, 2008 and(b) General corporate purposes.

Business Description

The Company is a generic pharmaceutical company with research and development, manufacturing,marketing and distribution capabilities. It focuses on the development, manufacturing, marketing anddistribution of generic finished dosage forms ("FDFs") through wholesalers, distributors, retailers and otherchannels, including hospitals and through open tenders. The Company also develops, manufactures...

Promoter's Holding
Total Share Capital    
Offered to Public    
Promoter's Holding (Pre-Issue)    
Promoter's Holding (Post-Issue)    
Address
Address :B/2

Mahalaxmi Chambers

22
Bhulabhai Desai Road
City :Mumbai, State :Maharashtra Pincode :400026 Phone :02240189999 Email : complianceofficer@glenmarkpharma.com Website : www.glenmark-generics.com
Registrar

Listed at
Lead Manager
Enam Securities Pvt Ltd
Kotak Mahindra Capital Co Ltd
Promoters
Glenmark Pharmaceuticals Ltd.
Open an Account
Contact Us